Showing 1 - 10 of 3,625
This paper examines the impact of labour and product market reforms on economic growth in 25 OECD countries between 1985 and 2013, and tests whether this impact is conditioned by the fiscal policy stance, i.e. whether there are fiscal expansions or adjustments. Our local projection results...
Persistent link: https://www.econbiz.de/10012238489
We study empirically how various labor market institutions - (i) union density, (ii) unemployment benefit remuneration, and (iii) employment protection - shape fiscal multipliers and output volatility. Our theoretical model highlights that more stringent labor market institutions attenuate both...
Persistent link: https://www.econbiz.de/10013201691
The empirical effectiveness of economic policies that operate theoretically through similar channels differs substantially. We document this fact by comparing an easy-to-grasp expectations-based policy, unconventional fiscal policy, with a policy whose implications are harder to understand by...
Persistent link: https://www.econbiz.de/10012057290
Persistent link: https://www.econbiz.de/10012304041
"We analyze the setting of monetary and nonmonetary policies in monetary unions. We show that in these unions a time inconsistency problem in monetary policy leads to a novel type of free-rider problem in the setting of nonmonetary policies, such as labor market policy, fiscal policy, and bank...
Persistent link: https://www.econbiz.de/10001720602
This paper, using a microfounded macroeconomic model that embeds the key features of the Greek economy, studies the … ECB, like the PEPP, for the Greek economy? Do they help the real economy and, if yes, by how much? What would have …
Persistent link: https://www.econbiz.de/10012650611
/busts, and in the presence of the zero lower bound. Studies on the effects of fiscal policy in open economy settings as well as …
Persistent link: https://www.econbiz.de/10011933907
Persistent link: https://www.econbiz.de/10011813918
The number of drugs approved by the FDA for treating cancer has increased substantially during the last 40 years. Moreover, cancer drug innovation has been accelerating: more than 8 times as many new cancer drugs were approved during 2005-2015 as were approved during 1975-1985 (66 vs. 8). During...
Persistent link: https://www.econbiz.de/10011735934
Persistent link: https://www.econbiz.de/10001644798